Module II: Drug Education

Topic 1
General Orientation on Republic Act No. 9165

Dangerous Drugs classified as prohibited and regulated has thus far been an ever-continuing
plague that had swept through most countries throughout the world.

Reported recently by the concerned government agencies and published in newspapers, the
Philippines being one amongst the poorest countries in Asia, is the favorite transit point of illegal
drugs by foreign drug syndicates and local drug lords also. These powerful vultures have found their
way through the pockets of corrupt officials from the government and its local agencies. This is often
additionally to the very fact that our international sea and airport, lack trained personnel, system, and
gadgets in detecting the smuggling of these illegal drugs.

The situation had been advantageous to drug syndicate in making the cost of operation more cost-
effective. This is often another reason why they have chosen the Philippines as their drug’s trade.

Most types of drugs that circulate within the Philippines came from foreign sources except
marijuana which is already being grown in some forested and swampy areas within the country. There
are reported situations wherein government agents have penetrated some plantations within the
remote mountain province which led to the arrest of violators and thus the uprooting of these
marijuana plants. Variety of those plantations are being maintained by government leftist to induce
income and finance their illegal activities.

Most dangerous drugs are often from overseas sources and are commonly coming from
neighboring Asian countries like Taiwan, Hongkong, Korea, and Japan, while others are coming from
the United States of America.

For some who were not knowledgeable enough, most dangerous drugs charge an extremely
expensive price in the streets and had an overwhelming demand. With the ever-increasing demand for
these drugs, most of the enterprising drug dealers have become millionaires.

The reduction of illegal drugs in the country is difficult especially if we only depend on the
authorities. Since drug abuse and trafficking is a threat and danger to the society as a whole, each
citizen could take part and play an important role as a support in our government’s campaign against
these illegal activities.

At present, our authorities are blanketed with economic issues sided by graft and corruption
which has been the primary cause for our authorities’ inability to resolve our current drug situation.
Our country doesn’t have enough manpower and logistics to combat the issues head-on, and it's about
time that we, citizens give concern and get involved in the battle towards these threats to society for
the welfare of our very own families.

COMPREHENSIVE DANGEROUS DRUGS ACT OF 2002

RA 9165 or Comprehensive Dangerous Drugs Act of 2002 approved on January 23, 2002, is also
known as “An Act Instituting The Comprehensive Dangerous Drug Act Of 2002, Repealing Republic

3
NATIONAL SERVICE TRAINING PROGRAM 1
6
 Module II: Drug Education

Act No. 6425, Otherwise Known As The Dangerous Drugs Act Of 1972, As Amended, Providing
Funds Therefor, And For Other Purposes”. Is a consolidation of Senate Bill No. 1858 and House Bill
No. 4433, it was enacted and passed by the Senate of the Philippines and House of Representatives of
the Philippines on May 30, 2002 and May 29, 2002, respectively. It was signed into law by President
Gloria Macapagal-Arroyo on June 7, 2002.

Comprehensive Dangerous Drugs Act of 2002 or Republic Act 9165 is an act that supersedes R A
6425 or the Dangerous Drugs Act of 1972. This amended law practices a more intensive approach
against drug abuse, trafficking and enforcement. It also gives emphasis on the role of the educational
system in information dissemination and prevention campaign. It re-evaluates the procedures, policies
and programs concerning drug abuse. It highlights the importance of rehabilitation and reintegration
of rehabilitated individuals to society

It is the policy of the state

1. to safeguard the integrity of its territory & the well-being of its citizenry, particularly the
youth, from the harmful effects of dangerous drugs on their physical & mental well-being,
and

2. to defend the same against acts or omissions detrimental to their development and
preservation

3. to provide effective mechanisms or measures to re-integrate into society individuals who have
fallen victims to drug abuse or dangerous drug dependence through sustainable programs of
treatment and rehabilitation

Toward this end, the government shall pursue an intensive and unrelenting campaign against the
trafficking and use of dangerous drugs.

Important provisions in the law

* Penalties range from six (6) months and one (1) day to life imprisonment and fines of ₱10,000.00 to
fifteen (15) million pesos depending on the person’s participation and sections of this law was
violated.

ARTICLE II. UNLAWFUL ACTS AND PENALTIES

Section 4. Importation of Dangerous Drugs and/or Controlled Precursors and Essential

Chemicals

Section 5. Sale, Trading, Administration, Dispensation, Delivery, Distribution and

Transportation of Dangerous Drugs and/or Controlled Precursors and
Essential Chemicals

Section 6. Maintenance of Den, Dive or Resort

Section 7. Employees and Visitors of Den, Dive or Resort

3
NATIONAL SERVICE TRAINING PROGRAM 1
7
 Module II: Drug Education

Section 8. Manufacture of Dangerous Drugs and/or Controlled Precursors and Essential

Chemicals

Section 9. Illegal Chemical Diversion of Controlled Precursors and Essential Chemicals

Section 10. Manufacture or Delivery of Equipment, Instrument, Apparatus and Other

Paraphernalia for Dangerous Drugs and/or Controlled Precursors and
Essential Chemicals

Section 11. Possession of Dangerous Drugs

Section 12. Possession of Equipment, Apparatus and Other Paraphernalia for Dangerous
Drugs

Section 13. Possession of Dangerous Drugs During Parties, Social Gatherings or Meetings

Section 14. Possession of Equipment, Apparatus and Other Paraphernalia for Dangerous
Drugs During Parties, Social Gatherings or Meetings

Section 15. Use of Dangerous Drugs

Section 16. Cultivation or Culture of Plants Classified as Dangerous Drugs or Are Sources
Thereof

Section 17. Maintenance and Keeping of Original Records of Transactions on Dangerous

Drugs and/or Controlled Precursors and Essential Chemicals

Section 18. Unnecessary Prescription of Dangerous Drugs

Section 19. Unlawful Prescription of Dangerous Drugs

Section 20. Confiscation and Forfeiture of the Proceeds or Instruments of the Unlawful Act,
Including the Properties or Proceeds Derived from the Illegal Trafficking of
Dangerous Drugs and/or Controlled Precursors and Essential Chemicals

Section 21. Custody and Disposition of Confiscated, Seized and/or Surrendered Dangerous
Drugs, Plant Sources of Dangerous Drugs and/or Controlled Precursors and
Essential Chemicals, Instruments/ Paraphernalia and/or Laboratory
Equipment

Section 22. Grant of Compensation, Reward and Award

Section 23. Plea-Bargaining Provision

Section 24. Non-Applicability of the Probation Law on Drug Traffickers and Pushers

Section 25. Qualifying Aggravating Circumstances in the Commission of a Crime by an

Offender under the Influence of Dangerous Drugs

Section 26. Attempt or Conspiracy

3
NATIONAL SERVICE TRAINING PROGRAM 1
8
 Module II: Drug Education

Section 27. Criminal Liability of a Public Officer or Employee for Misappropriation,

Misapplication or Failure to Account for the Confiscation, Seized or
Surrendered Dangerous Drugs, Plant Sources of Dangerous Drugs and/or
Controlled Precursors and Essential Chemicals, Instruments/Paraphernalia
and/or Laboratory Equipment Including the Proceeds or Properties Obtained
from the Unlawful Act Committed

Section 28. Criminal Liability of Government Officials and Employees

Section 29. Criminal Liability for Planting of Evidence

Section 30. Criminal Liability of Officers of Partnerships, Corporations, Associations or

Other Judicial Entities

Section 31. Additional Penalty if Offender is an Alien

Section 32. Liability of a Person Violating Any Regulation Issued by the Board

Section 33. Immunity from Prosecution and Punishment

Section 34. Termination of the Grant of Immunity

Section 35. Accessory Penalties

ARTICLE IV. PARTICIPATION OF THE FAMILY, STUDENTS, TEACHERS AND

SCHOOL AUTHORIIES IN THE ENFORCEMENT OF THIS ACT

Section 41. Involvement of the Family

Section 42. Student Councils and Campus Organizations

Section 43. School Curricula

ARTICLE IX. DANGEROUS DRUGS BOARD AND PHILIPPINE DRUG

ENFORCEMENT AGENCY

Section 77. The Dangerous Drugs Board

Section 78. Composition of the Board

Section 79. Meetings of the Board

Section 80. Secretariat of the Board

Section 81. Powers and Duties of the Board

Section 82. Creation of the Philippine Drug Enforcement Agency (PDEA)

Section 83. Organization of the PDEA

Section 84. Powers and Duties of the PDEA

3
NATIONAL SERVICE TRAINING PROGRAM 1
9
 Module II: Drug Education

Section 85. PDEA Academy

Section 86. Transfer, Absorption and Integration of All Operating Units on Illegal Drugs into
the PDEA and Transitory Provisions

NATURE OF DRUGS

Drug defined

Drug means (1) articles recognized in the Official United States Pharmacopoeia, Official
Homeopathic Pharmacopoeia of the United States, or Official National Formulary, or any supplement
to them; and (2) articles intended for use in the diagnosis, cure4, mitigation, treatment, or prevention
of disease in man or other animals; and (3) articles (other than food) intended to affect the structure or
any function of the body of an or animals; and (4) articles intended for use as a component of any
articles specified in clauses (1), (2), or (3), but not include devices or their components, parts, or
accessories (Senate Bill No. 674, Section 5).

A substance used as a medication or in the preparation of medication that affects the body and
mind, and have potential for abuse. Without an advice or prescription from a physician, can be
harmful in such as to bring physiological, emotional or behavioral change. It may be legal (e.g.
alcohol, caffeine and tobacco) or illegal (e.g. cannabis, ecstasy, cocaine and heroin).

Dangerous Drug defined

Includes those listed in the Schedules annexed to the 1961 Single Convention on Narcotic Drugs,
as amended by the 1972 Protocol and the Schedules annexed to the 1971 Single Convention on
Psychotropic Substances (R.A. No. 9165, Article I, Section 3). It also includes drugs, which are
hereinafter added to the list of dangerous drugs pursuant to Section 93 of R.A. No. 9165.

Dangerous drugs are those that have high tendency for abuse and dependency, these substances
may be organic, synthetic, and pose harm to those who use them.

Example:

Methylenedioxymethamphetamine (known as Ecstasy); Tetrahydrocannabinol (MJ);

Mescaline (Peyote).

I. Dangerous Drugs Identities

Dangerous drugs refer to the broad categories or classes of controlled substances. Controlled
substances are generally grouped according to pharmacological classifications, effects and as to
their legal criteria.

General Drug Classification

A. According to Effects, the dangerous drugs are classified as:

1. Depressants – are group of drugs that has the effect of slowing down or depressing
the central nervous system (however, they don’t really make you feel depressed).
4
NATIONAL SERVICE TRAINING PROGRAM 1
0
 Module II: Drug Education

Depressant drugs includes: alcohol, opiates and opioids, cannabis, minor

tranquilizers/benzodiazepines (benzos), some solvents and inhalants.

2. Stimulants – are group of drugs having the effect of speeding up the functions or
stimulating the central nervous system

A lot of people use the following stimulants every day: caffeine, nicotine and
ephedrine.

Stronger stimulant drugs include: amphetamines and methamphetamines, cocaine,

slimming tablets and dexamphetamine.

3. Hallucinogens – refers to the group of drugs that are considered to be mind altering
drugs, give the general effect of mood distortion and distorts the user’s perception of
reality.

This drugs include: LSD (lysergic acid diethylamide), magic mushroom (psilocybin),
mescaline (peyote mushroom), ecstasy (MDMA/methylenedioxymethamphetamine),
and ketamine.

B. According to Medical Pharmacology, dangerous drugs are classified as:

1. Depressants

2. Narcotics

3. Tranquilizers

4. Stimulants

5. Hallucinogens

6. Solvents/Inhalants

C. According to Legal Categories (in accordance to R.A. 6425). Pursuant to Republic Act
No. 6425, the Dangerous Drugs Act of 1972, the dangerous drugs are classified as:

1. Prohibited Drugs

a. Narcotics – refers to the group of drug opium and its derivatives, Morphine,
Heroin, Codeine, etc., including synthetic opiates

b. Stimulants – refers to the group of drug Cocaine, Alpha and Beta Eucaine, etc.

c. Hallucinogens – refers to the group of drugs like Marijuana, LSD (lysergic acid
diethylamide), mescaline, etc.

2. Regulated Drugs

4
NATIONAL SERVICE TRAINING PROGRAM 1
1
 Module II: Drug Education

a. Barbiturates – refers to the group of depressant drug known as “Veronal” like

Luminal, Amytal, Nembutal, Surital, Butisol, Penthonal, Seconal, etc.

b. Hypnotics – are group of drugs such as Mandrax, Quaalude, Fadormir, and

others.

c. Amphetamines – are group of stimulant drugs like Benzedrine, Dexedrine,

Methedrine, Preludin, etc.

3. Volatile Substances (P.D. 1619)

The group of liquid, solid or mixed substances having the property or releasing toxic
vapors or fumes which when sniffed, smelled, inhaled or introduced into the
physiological system of body produces or induces a condition of intoxication,
excitement or dulling of the brain or nervous system. Examples of these drugs are
Glue, Gasoline, Kerosene, Ether, Paint, Thinner, Lacquer, etc.

* NOTE: The passage of Republic Act 9165, Comprehensive Drug Law declassified the
above legal classification into one whole definition of dangerous drugs to include their
essential ingredients and precursors or chemical elements.

II. Classification of Dangerous Drugs (According to Effects)

The Depressants (Downers)

These are drugs which suppress vital body functions especially those in the brain or central
nervous system which resulting to impairment of judgment, hearing, speech and muscular
coordination.

In moderate doses, depressants can make you feel relaxed. Some depressants cause
euphoria and a sense of calm and well-being. They may be used to ‘wind down’ or to reduce
anxiety, stress or inhibition. Because they slow you down, depressants affects coordination,
concentration, and judgment, making driving and operating machinery hazardous.

In larger doses, depressants can cause unconsciousness by reducing breathing and heart
rate. A person’s speech may become slurred and their movements sluggish and uncoordinated.
Other effects of larger doses includes nausea, vomiting, and in extreme cases death. When taken
in combination, depressants increase their effects and increase the danger of overdose.

Depressant drugs include the narcotics, barbiturates, tranquilizers, alcohol and other volatile
solvents. These drugs, when taken in, generally decrease both the mental and physical activities
of the body. These drugs causes depression relieve pain and induce sedation or sleep and
suppress cough.

1. Narcotics – also called Opiates, re a group of drugs that are used medically to relieve pain,
and produce profound sleep or stupor when introduce to the body but have a high potential
for abuse. Medically, they are potent pain killers, cough depressants and as an active
component of anti-diarrhea preparations. Some opiates come from a resin taken from the
seedpod of the Asian poppy. Opiates that are commonly abused are Opium, Morphine,
Codeine, and synthesized or manufactured opiates as meperidine and methadone.
4
NATIONAL SERVICE TRAINING PROGRAM 1
2
 Module II: Drug Education

2. Opium - refers to the coagulated juice of the opium poppy (Papaver Somniferum L.) which
originates in Mesopotamia and embraces every kind, class and character of opium, whether
crude or prepared; the ashes or refuse of the same, narcotic preparations thereof or
therefrom; morphine or any alkaloid of opium; preparations in which opium, morphine or
any alkaloid of opium enters as an ingredient; opium poppy; poppy straw; and leaves or
wrappings of opium leaves, whether prepared for use or not. Popularly known as “gum”,
“gamut”, “kalamay” or “panocha”. Its active ingredient is the “meconic” acid – the
analgesic property.

3. Morphine – most commonly used and best used opiate. Effective as a pain killer six times
than opium, with a high dependence-producing potential. Morphine exerts action
characterized by analgesia, drowsiness, mood changes, and mental clouding.

4. Heroin – is three to five times more powerful than morphine from which it is derived and
the most addicting opium derivative. With continued use, addiction occurs within 14 days.
It may be sniffed, swallowed but is usually injected in the veins. Also known as “H”,
“hammer”, “smack”, “hell dust”, and “gear”.

5. Codeine – a derivative of morphine, commonly available in cough preparations. These

cough medicines have been widely abused by youth whenever hard narcotics are difficult to
obtain. Withdrawal symptoms are less severe than other drugs.

6. Paregoric – a tincture of opium in combination of camphor. Commonly used as a household

remedy for diarrhea and abdominal pain.

7. Demerol and Methadone – common synthetic drugs with morphine-like effects. Demerol is
widely used as a painkiller in childbirth while methadone is the drug of choice in the
withdrawal treatment of heroin dependents since it relieves the physical craving for heroin.

8. Barbiturates – are dugs used for inducing sleep in persons plagued with anxiety, mental
stress and insomnia. They are also of value in the treatment of epilepsy and hypertension.
They are available in capsules, pills or tablets, and taken orally or injected.

9. Seconal – commonly used among hospitality girls. Sudden withdrawal from these drugs is
even more dangerous than opiate withdrawal. The dependent develops generalized
convulsions and delirium, which are frequently associated with heart and respiratory failure.

10. Tranquilizers – are drugs used that calm and relax and diminish anxiety. They are used in
the treatment of nervous states and some mental disorders without producing sleep.

11. Volatile Solvents – gaseous substances popularly known to abusers as “gas”, “teardrops”.
Examples are plastic glues, hair spray, finger nail polish, lighter fluid, rugby, paint, thinner,
acetone, turpentine, gasoline, kerosene, varnishes and other aerosol products. They are
inhaled by the use of plastic bags, handkerchief of rags soaked in these chemicals.

12. Alcohol – the king of all drugs with potential for abuse. It is considered the most widely
used, socially accepted and most extensively legalized drug throughout the world.

The Stimulants (Uppers)

4
NATIONAL SERVICE TRAINING PROGRAM 1
3
 Module II: Drug Education

They produce effects opposite to that of depressants. Instead of bringing about relaxation
and sleep, they produce increased mental alertness, wakefulness, reduce hunger, and provide a
feeling of wellbeing. Their medical users include narcolepsy – a condition characterized by an
overwhelming desire to sleep.

Stimulants speedup or stimulate the central nervous system and can make the users feel
more awake, alert and confident. Stimulants increase heart rate, body temperature and blood
pressure. Other physical effects include reduced appetite, dilated pupils, talkativeness, and sleep
disturbance.

Higher doses of stimulants can ‘over stimulate’ users, causing anxiety, panic, seizures,
headaches, stomach cramps, aggression, and paranoia. They can also cause heart problems such
as arrhythmia, prolonged or sustained use of strong stimulants can also cause these effects.

Strong stimulants can mask the effects of depressant drugs, such as alcohol. This can
increase the potential for aggression and poses an obvious for hazard. Abrupt withdrawal of the
drug from the heavy abuser can result in a deep and suicidal depression.

1. Amphetamine – drugs which speed up the messages travelling between the brain and the
body. Used medically for weight reducing in obesity, relief of mild depression. Some types of
amphetamines are legally prescribed by doctors to treat conditions such as attention deficit
hyperactivity disorder (ADHD) and narcolepsy (where a person has an uncontrollable urge to
sleep). Amphetamines have also been used to treat Parkinson’s disease. Other types of
amphetamines such as speed are produced and sold illegally.

2. Cocaine – the drug taken from coca bush plant (Erythroxylum Coca) grows in South America.
Also known as ‘coke’ or ‘snow’. It is usually in the form of powder that can be taken, orally,
injected or sniffed as to achieve euphoria or an intense feeling of “highness”.

3. Caffeine – it is present in coffee, tea, chocolate, cola drinks and some wake-up pills.

4. Methamphetamine – other names as ‘shabu’, ‘poor man’s cocaine’, ‘ice’, ‘crystal’, and
‘meth’. It is a central nervous system stimulant. It is white, colorless crystal or crystalline
powder with a bitter numbing taste, it can be taken orally, inhaled (snorted), sniffed (chasing
the dragon) or injected.

5. Nicotine – an addictive substance found in tobacco cigarettes and cigars which acts as a
powerful stimulant of the central nervous system. Nicotine is actually one of the most habit-
forming substances that exist. In fact, nicotine addiction is often compared to the intense
addictiveness associated with opiate like heroin. A drop a pure nicotine can easily kill a
person.

The Hallucinogens (Psychedelic)

These are group of drugs that consists of a variety of mind-altering drugs, which distorts
reality, thinking and perceptions of time, sound, space and sensation. The user experiences
hallucination (false perception) which at times can be strange. His “trips” may be exhilarating
or terrifying good or bad. They may dislocate his consciousness and change his mood, thinking

4
NATIONAL SERVICE TRAINING PROGRAM 1
4
 Module II: Drug Education

and concept of self. There are many different kinds of psychedelics. Some occur naturally, in
trees, vines, seeds, fungi and leaves. Others are made in laboratories.

The effects of hallucinogens are not easy to predict and the person may behave in ways that
appear irrational or bizarre. Psychological effects often depends on the mood of the users and
the context of use. Negative effects may include panic, paranoia and loss of contact with reality.
In extreme cases, this can result in dangerous behaviour that can put the user and others at great
risk.

1. Marijuana – it is the most common abused hallucinogen in the Philippines because it can be
grown extensively in the country. Marijuana is the term used to describe all the plant material
like leaves, tops, stems, flowers and roots from a cannabis plant (Cannabis sativa), dried and
prepared for smoking or taken orally as “brownies”. Many users choose to smoke marijuana
for relaxation in the same way people drink beer or cocktail at the end of the day. The effects
of marijuana include a feeling of grandeur. It can also produce the opposite effect, a dreamy
sensation of time seeming to stretch out.

2. Lysergic Acid Diethylamide (LSD) – also known as ‘trips’, ‘acid’, and ‘microdots’. This drug
is the most powerful of the psychedelics obtained from ergot, a fungus that attacks rye
kernels. LSD is 1,000 times more powerful than marijuana as supply, large enough for a trip
can be taken from the glue on the flab of an envelope, from the hidden areas inside one’s
clothes. LSD causes perceptual changes so that the user sees color, shapes or objects more
intensely than normal and may have hallucinations of things that are not real. To him real
objects seem to change, building seems to be crackling open, and walls pulsating. He
experiences frequent bizarre hallucinations, loss spatial perceptions, personality diffusion and
changes in values. Usually users perceive distortion of time, colors, sounds and depth. They
experience “scent” music and sounds in “color”.

3. Peyote – derived from the surface from the surface part of a small gray brown cactus. Peyote
emits a nauseating odor and its users suffers from nausea. This drug causes no physical
dependence and therefore, no withdrawal symptoms; although in some cases psychological
dependence has been noted.

4. Mescaline – it is alkaloid hallucinogen extracted from the peyote cactus and can also be
synthesized in the laboratory. It produces less nausea than peyote and shows effects
resembling those of LSD although milder in nature. One to two hours after the drug is taken
in a liquid or powder form, delusions begin to occur. Optical hallucinations follow one upon
another in rapid succession. These are accompanied by imperfect coordination and perception
with a sensation of impeded motion, and a marked sense that time is still standing. Mescaline
does not cause physical dependence.

5. Psilocybin – it is also called as magic mushrooms but more popularly known as “mushies” are
wild or cultivated mushrooms that contain psilocybin, a naturally-occurring psychoactive and
hallucinogenic compound. Psilocybin is considered one of the most well-known psychedelics,
according to the Substance Abuse and Mental Health Services Administrations. These
mushrooms induced nausea, muscular relaxation, mood changes with visions of bright colors
and shapes, and other hallucinations. These effects may last for four to five hours and later be
followed by depressions, laziness and complete loss of time and space perceptions.

4
NATIONAL SERVICE TRAINING PROGRAM 1
5
 Module II: Drug Education

6. Methylenedioxymethamphetamine (MDMA) – Commonly known as "Ecstasy", "X-TC",

"Adam", "Eden Tablet", or by its any other name - refers to the drug having such chemical
composition, including any of its isomers or derivatives in any form; "Ecstasy", the other
trendy drug, is the term used for a group of "designer" drugs closely related in chemical form
to the amphetamine family of illicit drugs. Methylenedioxymethamphetamine or MDMA is
the chemical name for "ecstasy" but it is also known as the yuppie drug, and the hug drug,
among others.

7. Ketamine – It is used by medical practitioners and veterinarians as an anaesthetic. It is

sometimes used illegally by people to get high. Ketamine can produce psychedelic effects,
causing a person to see, hear, smell, feel or taste things that aren’t really there or are different
from how they are in reality. When it’s sold illegally, ketamine usually comes as a white
crystalline powder. It can also be made into tablets and pills, or dissolved in a liquid. Also
known as ‘K’ and ‘Special K’.

Commonly Abused drugs and Their Effects

Substance & Effects
Method of Use

ALCOHOL Alcohol’s effects vary from person to

person, depending on a variety of
People drink to socialize, factors, including:
celebrate, and relax. Alcohol
often has a strong effect on people  How much you drink
—and throughout history, people  How often you drink
have struggled to understand and  Your age
manage alcohol’s power.  Your health status
 Your family history.

COCAINE Short-term:
A powerfully addictive stimulant  Narrowed blood vessels;
drug made from the leaves of the  Enlarged pupils;
coca plant native to South  Increased body temperature, heart
America. rate, and blood pressure;
 Headache;
Common Forms: White powder,  Abdominal pain and nausea;
whitish rock crystal  Euphoria;
 Increased energy, alertness;
Common Ways Taken:
 Insomnia, restlessness;
 Snorted,  Anxiety;
 Erratic and violent behavior, panic attacks, paranoia, psychosis;
 Smoked,  Heart rhythm problems, heart attack;
 Stroke, seizure, coma
 Injected
Long-term:
 Loss of sense of smell, nosebleeds, nasal damage and trouble
swallowing from snorting;
 Infection and death of bowel tissue from decreased blood flow;
 Poor nutrition and weight loss;
 Lung damage from smoking.

Substance & Effects

Method of Use

4
NATIONAL SERVICE TRAINING PROGRAM 1
6
 Module II: Drug Education

ECSTASY (MDMA) Short-term:

A synthetic, psychoactive drug  Lowered inhibition;
that has similarities to both the  Enhanced sensory perception;
stimulant amphetamine and the  Increased heart rate and blood
hallucinogen mescaline. MDMA pressure;
is an abbreviation of the scientific  Muscle tension; nausea;
name 3, 4-methylenedioxy-  Faintness;
methamphetamine.  Chills or sweating;
 Sharp rise in body temperature leading to kidney failure or death.
Common Forms: Colorful tablets
with imprinted logos, capsules, Long-term:
powder, liquid
 Long-lasting confusion, depression, problems with attention, memory,
Common Ways Taken: and sleep;
 Increased anxiety, impulsiveness;
 Swallowed,  Less interest in sex.
 Snorted

MARIJUANA Short-term:
Marijuana is made from the hemp  Enhanced sensory perception and euphoria followed by
plant, Cannabis sativa. The main drowsiness/relaxation;
psychoactive (mind-altering)
chemical in marijuana is delta-9-  Slowed reaction time;
tetrahydrocannabinol, or THC.
Common Forms: Greenish-gray  Problems with balance and coordination;
mixture of dried, shredded leaves,
stems, seeds, and/or flowers; resin  Increased heart rate and
(hashish) or sticky, black liquid appetite;
(hash oil)
 Problems with learning and
Common Ways Taken: memory;
 Smoked,
 Anxiety.
 Vaped
Long-term:
 Eaten (mixed in food or
brewed as tea)  Mental health problems,
 Chronic cough,
 Frequent respiratory infections.

METHAMPHETAMINE Short-term:
An extremely addictive stimulant  Lowered inhibition;
amphetamine drug.  Enhanced sensory perception;
 Increased heart rate and blood
Common Forms: White powder pressure;
or pill; crystal meth looks like  Muscle tension; nausea;
pieces of glass or shiny blue-  Faintness;
white "rocks" of different sizes  Chills or sweating;
 Sharp rise in body temperature leading to kidney failure or death.
Common Ways Taken:
 Swallowed, Long-term:

 Snorted,  Long-lasting confusion, depression, problems with attention, memory,

and sleep;
 Smoked,  Increased anxiety, impulsiveness;
 Less interest in sex.

4
NATIONAL SERVICE TRAINING PROGRAM 1
7
 Module II: Drug Education

 Injected

Substance & Effects

Method of Use

TOBACCO (and NICOTINE) Short-term:

Tobacco is a plant grown for its  Increased blood pressure, breathing, and heart rate.
leaves, which are dried and  Exposes lungs to a variety of chemicals.
fermented before use. Tobacco  Vaping also exposes lung s to metallic vapors created by heating the
contains nicotine, an addictive coils in the device.
chemical. Nicotine is sometimes
extracted from the plant and is Long-term:
used in vaping devices.  Greatly increased risk of cancer, especially lung cancer when smoked,
Common Forms: cigarettes, and oral cancers when chewed;
vaping devices, e-cigarettes,  Chronic bronchitis;
cigars, bidis, hookahs, kreteks  Emphysema; heart disease;
Smokeless tobacco: snuff, spit  Leukemia;
tobacco, chew  Cataracts;
 Pneumonia.
Common Ways Taken:
 Smoked,
 Snorted,
 Chewed,
 Vaporized

Source: National Institute on Drug Abuse, June 2020

4
NATIONAL SERVICE TRAINING PROGRAM 1
8
 Module II: Drug Education

DRUG MENACE

One of the problems that is severely affecting the Filipino youth and society today is drug
addiction. Many organizations, both public and private, have given this problem a prime concern.
However, as more means are pooled together to diminish, if not resolve this problem, reported cases
of drug dependents continue to soar.

A. BASIC CONCEPTS

a. DRUG ABUSE Defined

The term Drug Abuse most often refers to the use of a drug with such frequency
which may be detrimental to the user’s physical, emotional, intellectual, or spiritual well-
being. Others referred to this as “substance abuse”.

b. DRUG DEPENDENCY Defined

Drug abuse must be distinguished from drug dependence. Drug dependence is

sometimes called drug addiction, is defined by three (3) basic characteristics (Groiler,
1995).

1. The users continue to take a drug over an extended period of time.

2. The users find it difficult to stop using the drug. They seem powerless to quit the
drug use. Users take extraordinary and often harmful measures to continue using
the drug. They will drop out of school, steal, leave their families, go to jail and
lose their job just to keep using drug.

3. The users stop taking their drug – only if their supply of the drug is cut off, or
they are forced to quit for any reason – they will undergo painful physical or
mental distress. The experience of withdrawal syndrome, is a sure sign that a
drug is dependency-producing and the user is dependent on the drug. Drug
dependence may lead to drug abuse – especially the illegal drugs.

c. DRUG ADDICTION Defined

Drug addiction is a state of mind in which a person has lost the power of self-control
in respect of a drug. He consumes the drug repeatedly leaving aside all values of life. In
other words a drug addict will resort to crime even, to satisfy his repeated craving for the
drug. The effects of addiction are mainly deteriorative personality changers. They include
insomnia, instability, and lack of self-confidence especially when not under the influence
of drug. The addict cannot concentrate on any work. He avoids social contacts. Slowly,
mentally, physically, and morally he becomes bad to worse and a burden to the society

 Characteristics of Drug Addiction

One or more of the following attributes characterizes drug addiction:

1. Uncontrollable Craving – the addict feels a compulsive craving to taker drug

repeatedly and tries to procure the same by any means.

2. Tolerance – it is the tendency to increase the dose of the drug to produce the
same effect as to that of the original effect.
4
NATIONAL SERVICE TRAINING PROGRAM 1
9
 Module II: Drug Education

3. Addiction – the addict is powerless to quit drug use.

4. Physical Dependence – the addict’s physiological functioning is altered. The

body becomes sick and incapable of carrying out useful activities in the
absence of the drug. The withdrawal syndromes will occur once the drug use
is stopped.

5. Withdrawal Syndrome – the addict becomes nervous and restless when he

does not get the drug. After about 12 hours, he starts sweating. His nose and
eyes become watery and continue doing so increasingly for another twelve
hours. It is followed by vomiting, diarrhea, loss of appetite and sleep.
Respiration, blood pressure and body temperature also rises. This will
continue up to three days. After which, the trouble starts subsiding and most
of it is gone in about a week’s time. Complete recovery takes place in three to
six months.

 Acquiring the Addiction

People have generally different motivation in life. The young ones are very much
adventurous and some of them have strong attraction in drug-taking, because
these “Space are era belongs to them so to speak, thus, the “IN” thing these days
are drugs. To see drug abusers around seemed to be a common sight.

The drug habit is acquired primarily in three ways:

1. Association – the tendency of a drug abuser to look for peer groups where he
feels being wanted and accepted.

2. Experimentation – the tendency of person to try and explore the effects of

drugs due to curiosity or other reasons.

3. Inexperienced doctors – the tendency of doctors and physician’s to

unnecessary prescribe drugs.

Likewise, addiction may also be acquired through:

1. Habituation – repetitious engagement of drug use which is closely related to

the experience of the euphoric effect of drugs, and the relief of pain or
emotional discomfort.

2. Toleration – refers to the necessity to increase the dose to obtain an effect

equivalent to the original dose.

3. Dependence – the altered physiological state brought about by the repeated

administration of the drug, which necessitates the continued use of the drug
to avoid withdrawal syndrome.

B. REASONS FOR DUG ABUSE

In the article from Recover Connection (2019), it listed ten (10) reasons why people use
drugs. It explains that there are circumstances that put a person to choose between properly
using drugs and abusing it. Here are the reasons.

5
NATIONAL SERVICE TRAINING PROGRAM 1
0
 Module II: Drug Education

1. Experimenting – It is not uncommon for addiction to stem from a person being

curious and experimenting with drugs or alcohol. It is a scenario that often starts with
a young person using alcohol or marijuana out of curiosity. While it seems harmless,
adolescents that experiment with drugs and alcohol are more likely to develop
substance use disorder according to the National Institute on Drug Abuse.

2. Family History Genetics – If you have a family history of drug addiction, you may
have a genetic predisposition to develop an addiction to drugs or alcohol. It is stated
that about 30 70 of a person’s risk for addiction is linked to the genes they are born
with along with other social factors.

3. Prescription Drugs – There is a popular misconception that any medication

prescribed by a doctor is safe. Unfortunately, that is not always the case. Doctors
prescribe medications to alleviate symptoms of physical or mental health issues.
However, many individuals are not properly educated on the risks that the
medications may carry. Chronic pain is often managed through opioid medications,
which are highly addictive. Dependent upon the amount used and other factors,
someone may require a medical detox just to stop using opioids. Likewise, those
suffering from anxiety and depression may be prescribed addictive medications to
ease symptoms. Non addictive medication and/or pain recovery services are often
available

4. Loneliness – Addiction can start when an individual feels lonely or is isolated from
the friends and family. They turn to drugs and alcohol thinking that it will fill a void
that they have been living with. People lacking positive daily interaction may choose
to use substances to feel happy or content. Additionally, users begin to alienate
themselves further if they fear being judged or that help is not available to them.

5. Peer Pressure – Peer pressure usually applies to adolescents or young adults. The
need to fit in, on some level, is built into each and every one of us. Some people may
feel the need to participate in potentially harmful activities to do so. The pressure of
being around others who are abusing drugs or alcohol can push someone to follow
suit.

6. Drugs And Alcohol Can Make You Feel Good – There is a popular quote in the Big
Book of Alcoholics Anonymous that states “Men and women drink essentially
because they like the effect produced by alcohol”. While this seems obvious, some
people like the effect so much that they are unable to stop. It may be difficult to see
the harm in something that makes you feel good.

7. Mental Health Disorder – Depression, anxiety, and PTSD can put individuals at
higher risk of developing an addiction. Using substances to cope with difficult
feelings may seem like an easier path for some. Though they may seem crippling at
times, there is help available to anyone struggling with a mental health disorder. Non-
narcotic medications are often available for most mental health disorders. It’s worth
researching with a doctor to see if there is an alternative to addictive medications.

8. Recreation – Many people use drugs or alcohol socially with friends or to “unwind”
after a long day. They often see substances as a way to relax or clear their minds.

5
NATIONAL SERVICE TRAINING PROGRAM 1
1
 Module II: Drug Education

Recreational drug users are still at risk to become addicted if their use becomes more
frequent or they use highly addictive substances.

9. Alcohol Isn’t Enough – For some, alcohol stops doing the trick. A few beers after
work or having drinks with friends at a local bar just doesn’t have the same effect that
it used to. Some individuals end up “chasing a buzz” that they were once able to
attain with a few drinks. This can leave someone powerless over alcohol and unable
to quit drinking.

10. Self-Medicating – People struggling with any of a multitude of ailments may turn to
drugs or alcohol to ease their pain. Mental health disorders and chronic pain leave
some seeking solutions on their own .Alcohol or other substances can alleviate
symptoms and seem like a short term solution. However, people should look for
manageable, long term solutions under medical supervision to combat these issues.

C. CLASSIFICATION OF DRUG ABUSERS

In order to understand the groups of people who abuse drugs, the group classification of
drug addicts are presented as:

1. Experimenters – people who abuse the drug(s) for experimental basis.

2. Occasional Users – abuse the drug occasionally/whenever there are special

occasions. They abuse the drug once every two (2) weeks to two (2) times a week.

3. Regular Users – abuse the drug on a regular basis approximately three (3) to four (4)
times a week or every other day.

4. Drug Dependents – people who tend to abuse the drug(s) everyday (almost every
day) or about five (5) to seven (7) times a week

5. Mentally Ill Chemical Abuser/Substance Induced Psychosis – drug abusers who

manifest signs and symptom of psychotic disorders caused by the effects of drugs
(disorientation, delusions, etc.).

D. COMMONLY SIGNS OF DRUG ABUSE

The profile of a drug dependent or a substance abuser is as follows:

 Changes in attendance in school or work

 Changes in the normal capabilities in school/work

 Abrupt changes in overall attitude

 Generally lazy, irritable, discourteous, aggressive

 Usually untrustworthy and lacks self confidence

 Manipulative

 Have a distorted view of reality

 Low frustration tolerance

 Con game player

5
NATIONAL SERVICE TRAINING PROGRAM 1
2
 Module II: Drug Education

 Lacks interest in his studies/work (withdrawal from responsibilities)

 Blames everybody but himself (blame tosser)

 No respect for the rights of others

 Prefers to stay with peers ‘barkada’

 May frequently go to odd places (to take drugs)

 Poor physical appearance (unconcerned with grooming and hygiene)

 Wearing of sunglasses at inappropriate times

 Unusual effort to cover arms to hide needle marks (long sleeved garments)

 Stealing items which can be readily sold

 Unusual borrowing of money from relatives and friends

 Association with known drug abusers

E. EFFECTS OF DRUG ABUSE

In several sources, it has been indicated that there are many effects of drug abuse. The
effects can be classified as follows:

1. Physiological/Physical Effects

a. Systematic

 Cardiac (Heart) Pathology – irregularity of heart beat, elevated or lowered

blood pressure, chest pain, convulsions o death from cardiac arrest.

 Pulmonary (Lung) Illness

 Hepatic (Liver) Problems

 Renal (Kidney) Diseases

b. General Health

 Malnutrition or weight loss

 Infections

 Accidents

 Blood Transmitted Disease

c. Usage

 Tolerance – the individual needs more drugs to achieve the same effects they
did previously with a smaller amount

 Dependence – the substance becomes the central point to the individual’s life
and they can’t function properly without it

5
NATIONAL SERVICE TRAINING PROGRAM 1
3
 Module II: Drug Education

 Withdrawal – this happens when the individual reduced or stopped the

substance use

 Overdose – the level of intoxication reaches a point where it begins to

produce physical and/or psychological harm. This can lead to death.

2. Psychological/Mental Health Effects

a. Perception – auditory and visual hallucinations

b. Orientation – paranoia, psychosis

c. Memory

d. Judgment – depression that lead to suicide

e. Stress – either heightening or weakening emotions

3. Economic Effects

a. Employment loss – individuals lose their effectivity and efficiency in the

workplace

b. Academic difficulties – for the youth, being unable to accomplish their course
work can affect their performance at school and their grades

c. Financial problems – addiction to substance requires more monetary resources

since the individual is forced to consume more of the substance to get their fix

4. Social Effects

a. Conflictual/Dysfunctional Relationships – an individual under the influence of

drugs creates tension and conflict with their family members and among their
peers that can result in broken relationships and abandonment

b. Violence – some of the chemicals in the abused substance can impaired the mind
to think illogically and to act aggressively that can have the individual act
violently in social settings

c. Safety – and individual under the influence of drugs can put someone in
dangerous circumstances and can be prone to accidents

F. PROFILE OF DRUG ABUSERS

Age Mean age of 32 years old
Sex Male to female ratio 9:1
Civil Status Single 51.20%
Family Size Siblings 3-4
Occupation Unemployed 50.06%
Educational
High School Level 28.14%
Attainment
Economic Status Average Family Income ₱11,265.10
Duration of Drug
More than six (6) years
Taking
Nature of Drug Taking Mono drug use (abuse of one drug only)

5
NATIONAL SERVICE TRAINING PROGRAM 1
4
 Module II: Drug Education

Methamphetamine Hydrochloride
(Shabu)
Abused Drugs
Cannabis (Marijuana)
Inhalants (Contact cement)
Place of Residence Urban, specially NCR 4.81%
Source: Dangerous Drugs Board (CY 2018)

G. SUBSTANCE DEPENDENCY AND KEEPING DRUG-FREE

 Drug Dependency Criteria

 Withdrawal symptoms

 Need to take drugs to overcome withdrawal symptoms

 Compulsion

 Tolerance Relapse

 Reduced social/occupational act

 How To Stay Away From Drugs?

 Devote yourself to your studies and other productive activities at home or in school

 Stay away from people, places and events that promote drug use

 Learn to manage feelings and cope with stress without using drugs

 Develop a strong moral and spiritual foundation

 Educate yourself about the effects of drug abuse

 Always say NO

 Counter-Measures for Substance Abuse

5
NATIONAL SERVICE TRAINING PROGRAM 1
5
 Module II: Drug Education

5
NATIONAL SERVICE TRAINING PROGRAM 1
6
 Module II: Drug Education

NATIONAL DRUG SITUATION

Source: PDEA Accomplishment Report 2018

A. DRUGS OF CHOICE IN THE PHILIPPINES

Methamphetamine
The Philippines is obviously not exempted from the global illegal Hydrochloride or Shabu

drug phenomena.
Based on PDEA’s intelligence and drug- related arrests,
methamphetamine hydrochloride, locally known as shabu, is the most
Cannabis or Marijuana
abused drug in the country, followed by cannabis or marijuana, and
methylenedioxy- methamphetamine (MDMA) or ecstasy.
During the first semester of the year, cocaine was recovered along
the Philippine shores by law enforcers and locals. However, there is no
conclusive indication that the cocaine was intended for local Methylenedioxymethampheta
consumption. mine (MDMA) or Ecstasy

The archipelagic set-up and strategic location of the country was

advantageous to drug syndicates who use the area as trans-shipment
point to smuggle drugs to consuming countries.
Benzoylmethylecgonine or
B. DRUGS OF CHOICE IN THE PHILIPPINES
Cocaine

Based on monitoring, shabu is traded on the streets at the average

price of Php6,800.00 per gram, marijuana at Php120.00 per gram or
Php40.00 per stick, and ecstasy at Php1,700.00 per tablet.

C. ILLEGAL DRUG TRAFFICKING

Five Chinese nationals (2 from Mainland
Illegal drug trafficking is a lucrative business and continues to China and 3 from Hong Kong) were
arrested during a series of operations
thrive in the Philippines. Drug groups and syndicates use conducted by PDEA on September 25,
2018 in Pasay City.
innovative methods to evade apprehension and expand their illegal
drug activities despite aggressive enforcement efforts. Despite
heightened law enforcement efforts, they continue with their illegal
drug activities.
Thus, supply of illegal drugs in the country is ensured by
international drug syndicates.
In 2018, three international drug syndicates have been monitored to be operating in the
Philippines.
The annual data on foreign nationals arrested in the country from 2002 to 2018 consistently
showed that Chinese nationals dominate the roll of arrested non-Filipino drug personalities. Out of
906 foreign nationals arrested in the country, 548 or 60% are Chinese.
The African Drug Syndicates (ADS) also smuggle drugs into
the country through airports using human drug couriers whom they
recruited in exchange for huge amount of money. From 2009 to
2018, 101 ADS members have been arrested in the Philippines.
On the other hand, the Mexican-Sinaloa drug cartel partners
with the Chinese drug syndicate to facilitate entry of illegal drugs Two Nigerian nationals arrested for selling
98.34 grams of shabu on March 9, 2018
during a buy-bust operation conducted by
PDEA in Bacoor City, Cavite
NATIONAL SERVICE TRAINING PROGRAM 1 5
7
 Module II: Drug Education

into the country. There have been reports that this South American/Latino drug trafficking
organization is trying to break into the Philippine market due to the demand for methamphetamine, a
comparatively low- cost production, high-yielding, and high- profit drug as compared to the
neighboring Southeast Asian countries who prefer heroin and cocaine. Latest monitored activity of the
syndicate was in 2017 when 2.2 kilograms of shabu, sent from DHL Mexico, were recovered at DHL
Warehouse at NAIA.
In April 2018, the fourth drug syndicate that is monitored to be operating in the country is the
Golden Triangle drug syndicate, which was connected with the dismantled three clandestine
laboratories owned by the syndicate in Batangas and Malabon City. The syndicate is involved in
large-scale production of methamphetamine in Myanmar for distribution in the Asia Pacific region.

D. BARANGAY DRUG AFFECTION

Barangay drug affectation depicts the level or extent of the drug problem in a certain barangay,
the

smallest political unit. As of December 2018, out of the total 42,045 barangays in the country, 22,041
or 52.42% are considered drug-affected.

5
NATIONAL SERVICE TRAINING PROGRAM 1
8
 Module II: Drug Education

Barangay drug afectation in the Philippines for FY

2018.

E. CLASSIFICATION OF BARANGAY DRUG AFFECTION

As provided in DDB Regulation No. 3, series of 2017, barangay drug-affectation is classified as
follows:
a. Drug Unaffected Barangay – has not ever been plagued or beset by any illegal drug activities
b. Drug Affected Barangay – has reported presence of drug user, pusher, manufacturer,
marijuana cultivator, or other drug personality, drug den, marijuana plantation, clandestine
laboratory, and facilities related to production of illegal drugs:
1. Seriously affected – reported presence of any of the following: clandestine drug
laboratory, warehouse, marijuana plantation and drug den/ tiangge, drug trafficking and
Validation smuggling
and Declaration of Drug
activities, Cleared
and drug Signing
personalities (i.e. and declaration
users, pushers, offinanciers,
Barangaysprotectors,
Pasian,
Barangays in Victoria, Oriental Mindoro on Rizal, San Jose, Baylo, and Inambatan, Monkayo,
cultivator, manufacturer and others);
October 8, 2018. Compostella Valley as drug-cleared barangays on
November 27, 2018.
2.

2. Moderately affected – reported presence of drug pusher/s and/or user/s; and

3. Slightly affected – reported presence of drug user/s.

5
NATIONAL SERVICE TRAINING PROGRAM 1
9
 Module II: Drug Education

c. Drug Cleared Barangay – classified as previously drug affected and subjected to drug
clearing operation and declared free from any illegal drug activities pursuant to the
parameters set forth by the regulation.

Map of Critical Areas in the

Philippines

CONTROLLED SUBSTANCES
According to legal-dictionary.thefreedictionary.com, controlled substance is a drug which has
been declared by federal or state law to be illegal for sale or use, but may be dispensed under a
physician's prescription. The basis for control and regulation is the danger of addiction, abuse,
physical and mental harm (including death), the trafficking by illegal means, and the dangers from
actions of those who have used the substances.
LIST OF CONTROLLED SUBSTANCES

 1971 UNITED NATIONS SINGLE CONVENTION ON PSYCHOTROPIC SUBSTANCES

Substances in Schedule I

6
NATIONAL SERVICE TRAINING PROGRAM 1
0
 Module II: Drug Education

Substances in this schedule have no currently accepted medical use in the United States, a
lack of accepted safety for use under medical supervision, and a high potential for abuse.
Some examples of substances listed in Schedule I are: heroin, lysergic acid diethylamide
(LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-
methylenedioxymethamphetamine ("Ecstasy").
International non- Other non-
proprietary name proprietary or Chemical name
(INN) trivial name
BROLAMFETAMINE DOB (±)-4-bromo-2,5-dimethoxy-alpha-
methylphenethylamine
CATHINONE (x)-(S)-2-aminopropiophenone
Not available DET 3-[2-(diethylamino)ethyl]indole
Not available DMA (±)-2,5-dimethoxy-alpha-methylphenethylamine
Not available DMHP 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-
trimethyl-6H-dibenzo[b,d]pyran-1-olo
Not available DMT 3-[2-(dimethylamino)ethyl]indole
Not available DOET (±)-4-ethyl-2,5-dimethoxy-alpha-phenethylamine
ETICYCLIDINE PCE N-ethyl-1-phenylcyclohexylamine
ETRYPTAMINE 3-(2-aminobutyl)indole
(+)-LYSERGIDE LSD, LSD-25 9,10-didehydro-N,N-diethyl-6-methylergoline-8beta-
carboxamide
Not available mescaline 3,4,5-trimethoxyphenethylamine
Not available methcathinone 2-(methylamino)-1-phenylpropan-1-one

4-methylaminorex (±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline
Not available MMDA 2-methoxy-alpha-methyl-4,5-
(methylenedioxy)phenethylamine
Not available N-ethyl MDA (±)-N-ethyl-alpha-methyl-3,4-
(methylenedioxy)phenethylamine
Not available N-hydroxy MDA (±)-N-[alpha-methyl-3,4-
(methylenedioxy)phenethyl]hydroxylamine
Not available parahexyl 3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
dibenzo[b,d]pyran-1-ol
Not available PMA p-methoxy-alpha-methylphenethylamine
Not available psilocine, psilotsin 3-[2-(dimethylamino)ethyl] indol-4-ol
PSILOCYBINE 3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen
phosphate
ROLICYCLIDINE PHP, PCPY 1-(1-phenylcyclohexyl)pyrrolidine
Not available STP, DOM 2,5-dimethoxy-alpha,4-dimethylphenethylamine
TENAMFETAMINE MDA alpha-methyl-3,4-(methylenedioxy)phenethylamine

TENOCYCLIDINE TCP 1-[1-(2-thienyl)cyclohexyl]piperidine

Not available tetrahydrocannabinol, the following isomers and their sterochemical variants:
7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d] pyran-1-ol
(9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-
1-ol (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl- 6H-
dibenzo[b,d]pyran-1-ol (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-
pentyl-6H- dibenzo[b,d]pyran -1- ol 6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-
6H-dibenzo[b,d] pyran-1-ol (6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-
9-methylene- 3-pentyl-6H- dibenzo[b,d]pyran-1-ol
Not available TMA (±)-3,4,5-trimethoxy-alpha-methylphenethylamine
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.

Substances in Schedule II

Substances in this schedule have a high potential for abuse which may lead to severe
psychological or physical dependence.
Examples of Schedule II narcotics include: hydromorphone (Dilaudid®), methadone
(Dolophine®), meperidine (Demerol®), oxycodone (OxyContin®, Percocet®), and fentanyl
(Sublimaze®, Duragesic®). Other Schedule II narcotics include: morphine, opium, codeine,
and hydrocodone.
Examples of Schedule IIN stimulants include: amphetamine (Dexedrine®, Adderall®),
methamphetamine (Desoxyn®), and methylphenidate (Ritalin®).

6
NATIONAL SERVICE TRAINING PROGRAM 1
1
 Module II: Drug Education

Other Schedule II substances include: amobarbital, glutethimide, and pentobarbital.

International non-
Other non-proprietary or
proprietary name Chemical name
trivial name
(INN)
AMFETAMINE amphetamine (±)-alpha-methylphenethylamine
DEXAMFETAMINE dexamphetamine (+)-alpha-methylphenethylamine
FENETYLLINE 7-[2-[(alpha-methylphenethyl)amino]
ethyl]theophylline
LEVAMFETAMINE levamphetamine (x)-(R)-alpha-methylphenethylamine
Not available levomethampheta-mine (x)-N,alpha-dimethylphenethylamine
MECLOQUALONE 3-(o-chlorophenyl)-2-methyl-4(3H)- quinazolinone
METAMFETAMINE methamphetamine +)-(S)-N,alpha-dimethylphenethylamine
METAMFETAMINE methamphetaminerace (±)-N,alpha-dimethylphenethylamine
RACEMATE mate
METHAQUALONE 2-methyl-3-o-tolyl-4(3H)-quinazolinone
METHYLPHENIDAT Methyl alpha-phenyl-2-piperidineacetate
E
PHENCYCLIDINE PCP 1-(1-phenylcyclohexyl)piperidine
PHENMETRAZINE 3-methyl-2-phenylmorpholine
SECOBARBITAL 5-allyl-5-(1-methylbutyl)barbituric acid
DRONABINOL * delta-9-tetrahydro- (6aR,10aR)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-
cannabinol and its 3-pentyl-6H- dibenzo[b,d]pyran-1-ol
stereochemical variants
ZIPEPROL alpha-(alpha-methoxybenzyl)-4-(beta-
methoxyphenethyl)-1-piperazineethanol
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.
* This INN refers to only one of the stereochemical variants of delta-9-tetrahydrocannabinol, namely (-)- trans-
delta-9-tetrahydrocannabinol.

Substances in Schedule III

Substances in this schedule have a potential for abuse less than substances in Schedules I
or II and abuse may lead to moderate or low physical dependence or high psychological
dependence.

Examples of Schedule III narcotics include: products containing not more than 90
milligrams of codeine per dosage unit (Tylenol with Codeine®), and buprenorphine
(Suboxone®).

Examples of Schedule IIIN non-narcotics include: benzphetamine (Didrex®),

phendimetrazine, ketamine, and anabolic steroids such as Depo®-Testosterone.
International non- Other non-
proprietary name proprietary or Chemical name
(INN) trivial name
AMOBARBITAL 5-ethyl-5-isopentylbarbituric acid
BUPRENORPHINE 2l-cyclopropyl-7-alpha-[(S)-1-hydroxy-1,2,2-
trimethylpropyl]-6,14- endo-ethano-6,7,8,14-
tetrahydrooripavine
BUTALBITAL 5-allyl-5-isobutylbarbituric acid
CATHINE (+)-norpseudo- (+)-(R)-alpha-[(R)-1-aminoethyl]benzyl alcohol
ephedrine
CYCLOBARBITAL 5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid
FLUNITRAZEPAM 5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-
benzodiazepin-2-one
GLUTETHIMIDE 2-ethyl-2-phenylglutarimide
PENTAZOCINE (2R*,6R*,11R*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-
(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol
PENTOBARBITAL 5-ethyl-5-(1-methylbutyl)barbituric acid
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.

Substances in Schedule IV

6
NATIONAL SERVICE TRAINING PROGRAM 1
2
 Module II: Drug Education

Substances in this schedule have a low potential for abuse relative to substances in
Schedule III.

Examples of Schedule IV substances include: alprazolam (Xanax®), carisoprodol

(Soma®), clonazepam (Klonopin®), clorazepate (Tranxene®), diazepam (Valium®),
lorazepam (Ativan®), midazolam (Versed®), temazepam (Restoril®), and triazolam
(Halcion®).
International non- Other non-
proprietary name proprietary or Chemical name
(INN) trivial name
ALLOBARBITAL 5,5-diallylbarbituric acid
ALPRAZOLAM 8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a]
[1,4]benzodiazepine
AMFEPRAMONE diethylpropion 2-(diethylamino)propiophenone
AMINOREX 2-amino-5-phenyl-2-oxazoline
BARBITAL 5,5-diethylbarbituric acid
BENZFETAMINE benzphetamine N-benzyl-N,alpha-dimethylphenethylamine
BROMAZEPAM 7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-
benzodiazepin-2-one
Not available butobarbital 5-butyl-5-ethylbarbituric acid
BROTIZOLAM 2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-
s-triazolo[4,3-a][1,4]diazepine
CAMAZEPAM 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-
1,4 benzodiazepin-2-one dimethylcarbamate (ester)
CHLORDIAZEPOXID 7-chloro-2-(methylamino)-5-phenyl-3H-1,4-
E benzodiazepine-4-oxide
CLOBAZAM 7-chloro-2-(methylamino)-5-phenyl-3H-1,4-
benzodiazepine-4-oxide
CLONAZEPAM 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-
benzodiazepin-2-one
CLORAZEPATE 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-
benzodiazepine-3-carboxylic acid
CLOTIAZEPAM 5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-
thieno [2,3-e] -1,4-diazepin-2-one
CLOXAZOLAM 10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydro-
oxazolo- [3,2-d][1,4]benzodiazepin-6(5H)-one
DELORAZEPAM 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-
benzodiazepin-2-one
DIAZEPAM 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-
benzodiazepin-2-one
ESTAZOLAM 8-chloro-6-phenyl-4H-s-triazolo[4,3-a]
[1,4]benzodiazepine
ETHCHLORVYNOL 1-chloro-3-ethyl-1-penten-4-yn-3-ol
ETHINAMATE 1-ethynylcyclohexanolcarbamate
ETHYL ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-
LOFLAZEPATE 1,4-benzodiazepine-3-carboxylate
ETIL AMFETAMINE N-ethylampetamine N-ethyl-alpha-methylphenethylamine
FENCAMFAMIN N-ethyl-3-phenyl-2-norborananamine
FENPROPOREX (±)-3-[(alpha-methylphenylethyl)amino]propionitrile
FLUDIAZEPAM 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-
1,4-benzodiazepin-2-one
FLURAZEPAM 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-
1,3-dihydro-2H-1,4-benzodiazepin-2-one
HALAZEPAM -chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-
2H-1,4-benzodiazepin-2-one
HALOXAZOLAM 10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-
tetrahydrooxazolo [3,2-d][1,4]benzodiazepin-6(5H)-one
KETAZOLAM 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-
[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7(6H)-dione
LEFETAMINE SPA (x)-N,N-dimethyl-1,2-diphenylethylamine
LOPRAZOLAM 6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-
piperazinyl) methylene]-8-nitro-1H-imidazo[1,2-a]
[1,4]benzodiazepin-1-one
LORAZEPAM 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-
1,4-benzodiazepin-2-one
LORMETAZEPAM 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-

6
NATIONAL SERVICE TRAINING PROGRAM 1
3
 Module II: Drug Education

methyl-2H-1,4-benzodiazepin-2-one
MAZINDOL 5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-
a]isoindol-5-ol
MEDAZEPAM 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-
benzodiazepine
MEFENOREX N-(3-chloropropyl)-alpha-methylphenethylamine
MEPROBAMATE 2-methyl-2-propyl-1,3-propanedioldicarbamate
MESOCARB 3-(alpha-methylphenethyl)-N-
(phenylcarbamoyl)sydnone imine
METHYLPHENOBARBITAL 5-ethyl-1-methyl-5-phenylbarbituric acid
METHYPRYLON 3,3-diethyl-5-methyl-2,4-piperidine-dione
MIDAZOLAM 8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a]
[1,4]benzodiazepine
NIMETAZEPAM 1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-
benzodiazepin-2-one
NITRAZEPAM 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-
one
NORDAZEPAM 7-chloro-1,3-dihdyro-5-phenyl-2H-1,4-benzodiazepin-2-
one
OXAZEPAM 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-
benzodiazepin-2-one
OXAZOLAM 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-
phenyloxazolo [3,2-d][1,4]benzodiazepin-6(5H)-one
PHENDIMETRAZINE (+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine
PHENOBARBITAL 5-ethyl-5-phenylbarbituric acid
PHENTERMINE alpha,alpha-dimethylphenethylamine
PINAZEPAM 7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-
benzodiazepin-2-one
PIPRADROL 1,1-diphenyl-1-(2-piperidyl)-methanol
PRAZEPAM 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-
2H-1,4-benzodiazepin-2-one
PYROVALERONE 4'-methyl-2-(1,-pyrrolidinyl)valerophenone
SECBUTABARBITAL 5-sec-butyl-5-ethylbarbituric acid
TEMAZEPAM -chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-
1,4-benzodiazepin-2-one
TETRAZEPAM 7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-
2H-1,4-benzodiazepin-2-one
TRIAZOLAM 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-
a][1,4]benzodiazepine
VINYLBITAL 5-(1-methylbutyl)-5-vinylbarbituric acid
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.

 1988 UNITED NATIONS CONVENTION AGAINST ILLICIT TRAFFIC IN NARCOTIC

DRUGS AND PSYCHOTROPIC SUBSTANCES
Table 1 Table 2
N-ACETYLANTHRANILIC ACID ACETIC ANHYDRIDE
EPHEDRINE ACETONE
ERGOMETRINE ANTHRANILIC ACID
ERGOTAMINE ETHYL ETHER
ISOSAFROLE HYDROCHLORIC ACID
LYSERGIC ACID METHYL ETHYL KETONE
3,4-METHYLENEDIOXYPHENYL-2- PHENYLACETIC ACID
PROPANONE
1-PHENYL-2-PROPANONE PIPERIDINE
PIPERONAL POTASSIUM PERMANGANATE
PSEUDOEPHEDRINE SULPHURIC ACID
SAFROLE TOLUENE
The salts of the substances listed in this Table The salts of the substances listed in this Table
whenever the existence of such salts is possible. whenever the existence of such salts is possible (the
salts of hydrochloric acid and sulphuric acid are
specifcally excluded)

6
NATIONAL SERVICE TRAINING PROGRAM 1
4
 Module II: Drug Education

OTHER PERTINENT LAWS

Republic The Dangerous Drugs Act of Signed into law by Approved on
Act No. 1972 President March 30, 1972
6425 Ferdinand E.
Marcos
Presidentia Penalizing the Use or Signed by Done on July 23,
l Decree Possession or the President 1979
No. 1619 Unauthorized Sale to Minors of Ferdinand E.
Volatile Substances for the Marcos
Purpose of Inducing
Intoxication or in Any Manner
Changing, Distorting or
Disturbing the Auditory, Visual
or Mental Process
Republic An Act Integrating Drug Enacted by the Approved on July
Act No. Prevention and Control in the Senate and House 11, 1992
7624 Intermediate and Secondary of Representatives
Curricula as Well as in the of the Philippines
Non-Formal, Informal and
Indigenous Learning Systems
and for Other Purposes
Republic Comprehensive Dangerous Signed into law by Approved on
Act No. Drugs Act of 2002 President Gloria January 23, 2002
6195 Macapagal-Arroyo
DDB Guidelines on the Custody and Dangerous Drugs October 18, 2002
Regulation Disposition of Seized Board
No. 1, S. Dangerous Drugs, Controlled
2002 Precursors and Essential
Chemicals, and Laboratory
Equipment
DDB Conduct of Controlled Delivery Dangerous Drugs November 22,
Regulation Operations Board 2002
No. 2, S.
2002
DDB Implementing Guidelines Dangerous Drugs May 30, 2003
Regulation Governing the Board
No. 1, S. Operationalization of the
2003 Special Drug Education
Centers
DDB Implementing Rules and Dangerous Drugs June 27, 2003
Regulation Regulations Governing Board
No. 2, S. Accreditation of Drug Testing
2003 Laboratories in the Philippines
DDB Comprehensive Guidelines on Dangerous Drugs July 4, 2003
Regulation Importation, Distribution, Board
No. 3, S. Manufacture, Prescription,
2003 Dispensing and Sale of, and
Other Lawful Acts in
connection with any
Dangerous Drugs, Controlled
Precursors and Essential
Chemicals and other Similar or
Analogous Substances
DDB Implementing Rules and Dangerous Drugs July 11, 2003
Regulation Regulations Governing Board
No. 4, S. Accreditation of Drug Abuse
2003 Treatment and Rehabilitation

6
NATIONAL SERVICE TRAINING PROGRAM 1
5
 Module II: Drug Education

Centers and Accreditation of

Center Personnel
DDB Guidelines in the Dangerous Drugs July 18, 2003
Regulation Implementation of Operation Board
No. 5, S. “Private Eye”
2003
DDB General Guidelines for the Dangerous Drugs August 1, 2003
Regulation Conduct of Random Drug Board
No. 6, S. Testing for Secondary and
2003 Tertiary Students
DDB General Guidelines for the Dangerous Drugs August 1, 2003
Regulation Implementation of Mandatory Board
No. 7, S. Drug Testing to ofcers and
2003 members of the Military,
Police, and other Law
Enforcement Agencies
DDB Guidelines for the Dangerous Drugs August 16, 2003
Regulation Implementation of a Drug-free Board
No. 8, S. Workplace Policies and
2003 Programs for the Private
Sector
DDB Adopting and Enforcing All Dangerous Drugs October 24, 2003
Regulation Previously Issued Dangerous Board
No. 9, S. Drugs Board
2003 Resolutions/Regulations and
other Issuances that are not
Inconsistent with the
Provisions of RA 9165
otherwise known as the
Comprehensive Dangerous
Drug Act of 2002
DDB Guidelines for the Dangerous Drugs November 21,
Regulation Implementation of Drug Board 2003
No. 10, S. Testing of Driver’s License
2003 Applicants
DDB Guidelines for the Dangerous Drugs November 21,
Regulation Implementation of Mandatory Board 2003
No. 11, S. Drug Testing to Applicants of
2003 Firearms License and Permit
to Carry Firearms outside of
Residence
DDB Re-use of the Polyethylene Dangerous Drugs December 5,
Regulation Bottles for Urine Collection in Board 2003
No. 12, S. Drug Testing
2003
DDB Prescribing Drug Test Fee for Dangerous Drugs February 27,
Regulation Government-owned and Board 2004
No. 1, S. Private Drug Testing
2004 Laboratories Accredited by the
Department of Health
DDB Guidelines for the Formulation Dangerous Drugs March 26, 2004
Regulation and Implementation of a Drug- Board
No. 2, S. free Workplace Program and
2004 the Conduct of Authorized
Drug Testing by all Ofces,
Bureaus, and Agencies of the
National and Local
Governments, Government-

6
NATIONAL SERVICE TRAINING PROGRAM 1
6
 Module II: Drug Education

owned and Controlled

Corporations and other
Institutes of Learning including
the State Colleges and
Universities
DDB Prescribing the Confrmatory Dangerous Drugs March 26, 2004
Regulation Drug Test Fee to be Paid by Board
No. 3, S. the Screening Drug Testing
2004 Laboratories to the
Department of Health (DOH)
Accredited Confrmatory
Laboratories
Executive Strengthening the Support By President Gloria
Order No. Mechanism for the Philippine Macapagal-Arroyo
218 Drug Enforcement Agency
DDB Amending Board Regulation Dangerous Drugs March 16, 2005
Regulation No.5 Series of 2003, entitled Board
No. 1, S. Guidelines in the
2005 Implementation of “Operation:
Private Eye”
DDB Rules on the Suspension of Dangerous Drugs July 19, 2005
Regulation Sentence of a First-time Minor Board
No. 2, S. Drug Ofender
2005
DDB Inclusion of Ketamine in the Dangerous Drugs July 19, 2005
Regulation List of Dangerous Drugs and Board
No. 3, S. Amending Section 32-6(b) of
2005 Board Regulation No.3, Series
2003 and in the List of
Dangerous Drugs to be
Prescribed in a Single
Applicable Prescription by a
Licensed Practitioner
DDB Reclassifying Ephedrine and Dangerous Drugs July 19, 2005
Regulation Pseudophedrine as Dangerous Board
No. 4, S. Drugs
2005
DDB Inclusion of Thionyl Chloride in Dangerous Drugs July 19, 2005
Regulation the List of Controlled Board
No. 5, S. Precursors and Essential
2005 Chemicals
DDB Guidelines in the Dangerous Drugs June 6, 2006
Regulation Implementation of the Board
No. 1, S. Aftercare Program for
2006 Recovering Drug Dependents
DDB Regulation Governing the Dangerous Drugs June 6, 2006
Regulation Implementation of Section 57 Board
No. 2, S. (Probation and Community
2006 Service under the Voluntary
Submission Program) and
Section 70 (Probation or
Community Service for a First-
time Minor Ofender in Lieu of
Imprisonment) of RA 9165
DDB Guidelines for the Drug Dangerous Drugs June 6, 2006
Regulation Profciency Testing (PT) Board
No. 3, S. Program for Drug Testing
2006 Laboratories (DTLs)

6
NATIONAL SERVICE TRAINING PROGRAM 1
7
 Module II: Drug Education

DDB Amending Board Regulation Dangerous Drugs December 6,

Regulation No.5, Series of 2003, Entitled Board 2006
No. 4, S. Guidelines in the
2006 Implementation of Operation
“Private Eye”
DDB Imposing Fines and other Dangerous Drugs December 6,
Regulation Sanctions for Violations Board 2006
No. 5, S. Committed on the Pertinent
2006 Provisions of Board Regulation
No.3, Series of 2003
DDB Prescribing the Procedures for Dangerous Drugs December 6,
Regulation Appeal regarding the Board 2006
No. 6, S. Implementation of Board
2006 Regulation No.3, Series of
2003
DDB Institutionalizing the Dangerous Drugs December 6,
Regulation Dangerous Drugs Board Board 2006
No. 7, S. Integrated Drug Abuse Data
2006 Information Network (DDB
IDADIN)
DDB Guidelines on the Disposition Dangerous Drugs March 20, 2007
Regulation of Confscated, Seized and/or Board
No. 1, S. Surrendered Dangerous
2007 Drugs, Plant Sources of
Dangerous Drugs, Controlled
Precursors and Essential
Chemicals,
Instruments/Paraphernalia,
and/or Laboratory Equipment
in connection with Cases
under Investigation,
Preliminary Investigation or
Reinvestigation
DDB Providing for Revised Dangerous Drugs June 6, 2007
Regulation Guidelines in the Conduct of Board
No. 2, S. Barangay Drug-Clearing
2007 Operations

Annex A and B - Organizing for

Barangay Drug-Clearing
Operations (Activites &
Flowchart) & Watchlist of Drug
Personalities
Annex C - Knowing the Enemy
(Identifying the Organizational
Structure of drug Syndicates
Operating in a Locality)
Annex D Petion for
Confnement & verifcation,
Certifcation of Non-Forum
Shopping
Annex D1 Application for
Voluntary Confnement for
Treatment and Rehabilitation
Annex D2 Application for
Voluntary Confnement for
Treatment and Rehabilitation
thru Representation

6
NATIONAL SERVICE TRAINING PROGRAM 1
8
 Module II: Drug Education

Annex E Certifcate of Drug-

Cleared Barangay
Annex F Report on Barangay
Drug-Clearing Operations
Annex G Report Format on
Advocacy & Preventive
Education Seminars
DDB Rules Governing Voluntary Dangerous Drugs June 6, 2007
Regulation Confnement for Treatment Board
No. 3, S. and Rehabilitation of Drug
2007 Dependents
DDB Amending certain Sections of Dangerous Drugs July 12, 2007
Regulation Board Regulation No.5, Series Board
No. 4, S. of 2003, entitled Guidelines in
2007 the Implementation of
Operation “Private Eye” as
amended by Board Regulation
No.4, Series of 2006
DDB Institutionalizing the Barkada Dangerous Drugs November 13,
Regulation Kontra Droga Program Board 2007
No. 5, S.
2007
DDB Classifying Toluene-Based Dangerous Drugs November 13,
Regulation Contact Cement Products Board 2007
No. 6, S. Without at Least Five Percent
2007 (5%) Mustard Oil Content as
Dangerous Drugs
DDB Amending Board Regulation Dangerous Drugs November 13,
Regulation No.3, Series of 2003, entitled Board 2007
No. 7, S. “Comprehensive Guidelines on
2007 Importation, Distribution,
Manufacture, Prescription,
Dispensing, and Sale of, and
other Lawful Acts in
connection with, any
Dangerous Drugs, Controlled
Precursors and Essential
Chemicals and other Similar or
Analogous Substances”
DDB Amending Board Regulation Dangerous Drugs December 11,
Regulation No.2, Series of 2003, entitled Board 2007
No. 8, S. “Implementing Rules and
2007 Regulations Governing
Accreditation of Drug Testing
Laboratories in the
Philippines”
DDB Amending Board Regulation Dangerous Drugs December 11,
Regulation No.1, Series of 2004, entitled Board 2007
No. 9, S. “Prescribing Drug Test Fee for
2007 Government-Owned and
Private Drug Testing
Laboratories Accredited by the
Department of Health”
DDB Uniform Drug Inventory and Dangerous Drugs December 11,
Regulation Tracking System Board 2007
No. 10, S.
2007
DDB Inclusion of Oripavine in the Dangerous Drugs May 14, 2008

6
NATIONAL SERVICE TRAINING PROGRAM 1
9
 Module II: Drug Education

Regulation List of Dangerous Drugs Board

No. 1, S.
2008
DDB Inclusion of Amineptine in the Dangerous Drugs
Regulation List of Dangerous Drugs Board
No. 2, S.
2008
DDB Amending Board Regulation Dangerous Drugs May 14, 2008
Regulation No.1, Series of 2007 entitled Board
No. 3, S. “Guidelines on the Disposition
2008 of Confscated, Seized and/or
Surrendered Dangerous
Drugs, Plant Sources of
Dangerous Drugs, Controlled
Precursors and Essential
Chemicals,
Instruments/Paraphernalia,
and/or Laboratory Equipment
in connection with Cases
under Investigation,
Preliminary Investigation or
Reinvestigation
DDB Amending Board Regulation Dangerous Drugs October 2, 2008
Regulation No.4, Series of 2003 entitled Board
No. 4, S. “Implementing Rules and
2008 Regulations Governing
Accreditation of Drug Abuse
Treatment and Rehabilitation
Centers and Accreditation of
Center Personnel”
DDB Creating the Committee on Dangerous Drugs October 23, 2008
Regulation Appeals of the Board and Board
No. 5, S. Prescribing the Procedures in
2008 Making an Appeal
DDB Guidelines on the Transfer/Re- Dangerous Drugs November 13,
Regulation assignment of Police Board 2008
No. 6, S. Witnesses
2008
DDB Guidelines for the Dangerous Drugs March 26, 2009
Regulation Rehabilitation of First Time Board
No. 1, S. Ofenders Under Section 15 of
2009 RA 9165 Who Are Not Drug
Dependents
DDB Implementing Guidelines for Dangerous Drugs April 21, 2009
Regulation the Implementation of Board Board
No. 2, S. Regulation No. 6, Series of
2009 2007, entitled Classifying
Toluene-Based Contact
Cement Products Without at
Least Five Percent (5%)
Mustard Oil Content as
Dangerous Drugs
DDB General Guidelines for the Dangerous Drugs June 3, 2009
Regulation Conduct of Random Drug Board
No. 3, S. Testing for Students of
2009 Secondary, Tertiary,
Vocational and Technical
Schools, Amending Board

7
NATIONAL SERVICE TRAINING PROGRAM 1
0
 Module II: Drug Education

Regulation No.6, Series of

2003
DDB Amending Section 18 and 19, Dangerous Drugs October 13, 2009
Regulation Article III of Board Regulation Board
No. 4, S. No.3, Series of 2003, entitled
2009 "Comprehensive Guidelines on
Importation, Distribution,
Manufacture, Prescription,
Dispensing and Sale of, and
Other Lawful Acts in
connection with, any
Dangerous Drugs, Controlled
Precursors and Essential
Chemicals and Other Similar
or Analogous Substances"
DDB Inclusion of N- Dangerous Drugs November 12,
Regulation Benzylpiperazine (BZP) in the Board 2009
No. 5, S. List of Dangerous Drugs
2009
DDB Inclusion of Nalbuphine Dangerous Drugs January 16, 2013
Regulation Hydrochloride in the List of Board
No. 1, S. Dangerous Drugs
2010
DDB Amending Board Regulation Dangerous Drugs September 12,
Regulation No. 1, Series 2002, entitled Board 2013
No. 1, S. "Guidelines on the Custody
2013 and Disposition of Seized
Dangerous Drugs, Controlled
Precursors and Essential
Chemicals, and Laboratory
Equipment" and for Other
Purposes.
DDB Inclusion of Methylephedrine Dangerous Drugs September 12,
Regulation in the list of dangerous drugs. Board 2013
No. 2, S.
2013
DDB Comprehensive Amendments Dangerous Drugs February 3, 2014
Regulation to Board Regulation No. 3 s Board
No. 3, S. 2003, "Comprehensive
2013 Guidelines on importation,
distribution, manufacture,
prescription, dispensing and
sale of, and other lawful acts
in connection with any
dangerous drugs, controlled
precursors and essential
chemicals and other similar or
analogous substances", as
amended, and other related
Board issuances
DDB Amendment to Board Dangerous Drugs December 12,
Regulation Regulation No. 7, Series of Board 2013
No. 4, S. 2003 Entitled "General
2013 Guidelines for the
Implementation of Mandatory
Drug Testing to Ofcers and
Members of the Military, Police
and Other Law Enforcement

7
NATIONAL SERVICE TRAINING PROGRAM 1
1
 Module II: Drug Education

Agencies"
DDB Comprehensive Amendments Dangerous Drugs March 13, 2015
Regulation to Board Regulation No. 3 Board
No. 1, S. Series 2003, "Comprehensive
2014 Guidelines on Importation,
Distribution, Manufacture,
Prescription, Dispensing and
Sale of, and Other Lawful Acts
in Connection with Any
Dangerous Drugs, Controlled
Precursors and Essential
Chemicals and Other Similar
or Analogous Substances", as
Amended, and Other Related
Board Issuances. (This Board
Regulation will take efect on
March 13, 2015)

Annex A - Philippine Schedules

of Dangerous Drugs
Annex B - Philippine Tables of
Controlled Precursors and
Essential Chemicals
Annex C - Regulatory
Proceedings to reclassify, add,
or remove from list
Annex D - Table of
Concentration Limits
Annex E - Pharmaceutical
Drugs in Airplanes and Vessels
Annex F - Administrative
Procedures in Suspending or
Revoking a License
Annex G - EUD
Annex H - Requisition sheet
Annex I - Registers
Annex J - Report Forms
Annex K - Registers
Annex L - Safekeeping,
storage, and transportation
Annex M - MSDS or GHS of
Classifcation of Controlled
Chemicals
R.A. No. An Act To Further Strengthen Approved by Approved on July
10640 The Anti-drug Campaign Of President Benigno 15, 2014
The Government, Amending S. Aquino III
For The Purpose Section 21 Of
Republic Act No. 9165,
Otherwise Known As The
"Comprehensive Dangerous
Drugs Act Of 2002"
DDB Inclusion of ALPHA- Dangerous Drugs September 9,
Regulation PHENYLACETOACETONITRILE Board 2015
No. 1, S. (“APAAN”) in the list of
2015 Controlled Precursors and
Essential Chemicals
DDB Inclusion of 1, 2-DIMETHYL-3- Dangerous Drugs September 9,
Regulation PHENYL AZIRIDINE and its CIS Board 2015

7
NATIONAL SERVICE TRAINING PROGRAM 1
2
 Module II: Drug Education

No. 2, S. and TRANS ISOMERS in the list

2015 of Controlled Precursors and
Essential Chemicals
DDB Inclusion of SALVIA Dangerous Drugs September 9,
Regulation DIVINORUM, its resin, extract, Board 2015
No. 3, S. tinctures or other forms and /
2015 or any part or portion thereof
in the list of Dangerous Drugs
DDB Guidelines in the Dangerous Drugs August 3, 2016
Regulation Implementation of Operation: Board
No. 1, S. "Lawmen"
2016
DDB Amending Section 2 of Board Dangerous Drugs August 3, 2016
Regulation Regulation No. 2, Series of Board
No. 2, S. 2007 Entitled "Providing for
2016 Revised Guidelines in the
Conduct of Barangay Drug-
Clearing Operations"
DDB Guidelines on Handling Dangerous Drugs August 3, 2016
Regulation Voluntary Surrender of Drug Board
No. 3, S. Personalities
2016
Attachment of Board
Regulation No. 3, Series of
2016 (Voluntary Surrender
Forms)
DDB Oplan Sagip - Guidelines on Dangerous Drugs September 19,
Regulation Voluntary Surrender of Drug Board 2016
No. 4, S. Users and Dependents and
2016 Monitoring Mechanism of
Barangay Anti-Drug Abuse
Campaigns
DDB Inclusion of Acetylfentanyl in Dangerous Drugs November 8,
Regulation the List of Dangerous Drugs Board 2016
No. 5, S.
2016
DDB Inclusion of 1- cyclohexyl- Dangerous Drugs November 8,
Regulation 4(1,2-diphenylethyl) Board 2016
No. 6, S. piperazine or MT-45 in the List
2016 of Dangerous Drugs
DDB Inclusion of methoxetamine or Dangerous Drugs November 8,
Regulation MXE in the List of Dangerous Board 2016
No. 7, S. Drugs
2016
DDB Inclusion of para- Dangerous Drugs November 8,
Regulation methoxymethlamphetamine Board 2016
No. 8, S. or PMMA in the List of
2016 Dangerous Drugs
DDB Inclusion of A- Dangerous Drugs November 8,
Regulation Pyrrolidinovalerophenone or A- Board 2016
No. 9, S. PVP in the List of Dangerous
2016 Drugs
DDB Inclusion of para-methyl-4- Dangerous Drugs November 8,
Regulation methylaminorex or 4,4'-DMAR Board 2016
No. 10, S. in the List of Dangerous Drugs
2016
DDB Inclusion of phenazepam in Dangerous Drugs November 8,
Regulation the List of Dangerous Drugs Board 2016

7
NATIONAL SERVICE TRAINING PROGRAM 1
3
 Module II: Drug Education

No. 11, S.
2016
DDB Amending Certain Sections of Dangerous Drugs February 14,
Regulation Board Regulation No. 10, Board 2017
No. 1, S. Series of 2007, Entitled:
2017 "Uniform Drug Inventory and
Tracking System"
DDB Adopting the Civil Service Dangerous Drugs February 14,
Regulation Commission Sanction of Board 2017
No. 2, S. Dismissal at First Ofense for
2017 Employees or Ofcials in the
Public Sector Who Are Tested
And Found Positive for Illegal
Drugs in the Amendment of
Sanctions Under Section 2 of
Board Regulation No. 2, Series
of 2004
DDB Strengthening the Dangerous Drugs February 14,
Regulation Implementation of Barangay Board 2017
No. 3, S. Drug Clearing Program
2017
Executive Creation of an Inter-Agency By President March 6, 2017
Order No. Committee on Anti-Illegal Rodrigo R. Duterte
15, S. 2017 Drugs (Icad) and Anti-Illegal
Drug Task Force to Suppress
the Drug Problem in the
Country
DDB Amending Section 1 of Board Dangerous Drugs January 24, 2018
Regulation Regulation No. 4, Series of Board
No. 1, S. 2005 "Reclassifying Ephedrine
2018 and Pseudoephedrine as
Dangerous Drugs" by
including the Isomers and
Salts of Isomers of Ephedrine
and Pseudoephedrine and by
including further their
Halogenated and Alkylated
forms thereof and the Salts,
Isomers, and Salts of Isomers
of these forms as well as any
material, compound, mixture
or preparation containing the
same, in the list of Dangerous
Drugs
DDB Balay Silangan - Guidelines for Dangerous Drugs January 24, 2018
Regulation Community Involvement in Board
No. 2, S. Reforming Drug Ofenders into
2018 Self-sufcient and Law-abiding
Members of Society
DDB Amending Section 3 (2) of Dangerous Drugs February 23,
Regulation Board Regulation No. 1, Series Board 2018
No. 3, S. of 2014 and Creating the
2018 Committee on Reclassifcation,
Addition or Removal of any
Drug/Substance from the List
of Dangerous Drugs/Controlled
Precursors and Essential
Chemicals

7
NATIONAL SERVICE TRAINING PROGRAM 1
4
 Module II: Drug Education

DDB Inclusion of 4- Dangerous Drugs April 4, 2018

Regulation Methylethcathinone (4-MEC) in Board
No. 4, S. the List of Dangerous Drugs
2018
DDB Inclusion of 5F-APINACA (5-F- Dangerous Drugs April 4, 2018
Regulation AKB-48) in the List of Board
No. 5, S. Dangerous Drugs
2018
DDB Inclusion of Ethylone in the Dangerous Drugs April 4, 2018
Regulation List of Dangerous Drugs Board
No. 6, S.
2018
DDB Inclusion of Ethylphenidate in Dangerous Drugs April 4, 2018
Regulation the List of Dangerous Drugs Board
No. 7, S.
2018
DDB Inclusion of MDMB-CHMICA in Dangerous Drugs April 4, 2018
Regulation the List of Dangerous Drugs Board
No. 8, S.
2018
DDB Inclusion of Methiopropamine Dangerous Drugs April 4, 2018
Regulation (MPA) in the List of Dangerous Board
No. 9, S. Drugs
2018
DDB Inclusion of Pentedrone in the Dangerous Drugs April 4, 2018
Regulation List of Dangerous Drugs Board
No. 10, S.
2018
DDB Inclusion of XLR-11 in the List Dangerous Drugs April 4, 2018
Regulation of Dangerous Drugs Board
No. 11, S.
2018
DDB Amending Section 2, Article II Dangerous Drugs July 9, 2018
Regulation and Section 7(e), Article IV of Board
No. 12, S. Board Regulation No. 5 Series
2018 of 2003, Entitled: Guidelines in
the Implementation of
"Operation: Private Eye", as
Further Amended by DDB
Board Regulation No. 1 Series
of 2005 and DDB Regulation
No. 4 Series of 2007
DDB Establishment and Dangerous Drugs August 30, 2018
Regulation Instituitionalization of Drug- Board
No. 13, S. Free Workplace Policies in all
2018 Government Ofces, Including
the Conduct of Authorized
Drug Testing for Elective Local
Ofcials and Appointive Public
Ofcers and for other
Purposes
Executive Institutionalizing the Philippine By President October 29, 2018
Order No. Anti-Illegal Drugs Strategy Rodrigo R. Duterte
66, S. 2018
DDB Implementing Rules and Dangerous Drugs February 7, 2019
Regulation Regulations Governing the Board
No. 1, S. Accreditation of Drug
2019 Rehabilitation Practitioners

7
NATIONAL SERVICE TRAINING PROGRAM 1
5
 Module II: Drug Education

DDB Implementing Rules and Dangerous Drugs February 7, 2019

Regulation Regulations Governing the Board
No. 2, S. Accreditation of Drug Abuse
2019 Treatment and Rehabilitation
Centers
DDB Classifcation of Plants that are Dangerous Drugs June 27, 2019
Regulation Listed in 1961 & 1971 as Board
No. 3, S. Dangerous Drugs
2019
DDB Inclusion of GBL, and All Dangerous Drugs June 27, 2019
Regulation Compounds,....in the List of Board
No. 4, S. Dangerous Drugs
2019
DDB SK Step Up Guidelines in Dangerous Drugs June 27, 2019
Regulation Institutionalizing Uniform Board
No. 5, S. preventive Education
2019
DDB Protocol When Handling Dangerous Drugs June 27, 2019
Regulation Children Allegedly Involved in Board
No. 6, S. Dangerous Drugs
2019
DDB Consolidated Revised Rules Dangerous Drugs
Regulation Governing Access to Board
No. 7, S. Treatment and Rehabilitation
2019 Programs and Services

Annex A - New Process Flow

Chart
Annex B - ASSIST Manual
Annex C - WHO - Self
Reporting Questionnaire (SRQ)
Manual
Annex D - Application for
Voluntary Confnement for
Treatment and Rehabilitation
Thru Representation
Annex E - Acronyms
Annex F - Defnition of Terms
Annex G - BADAC Form 1
Annex H - Community-Based
Monitoring Form
Annex I - DDB IDADIN FORM 6-
06
DDB Requirements for the Issuance Dangerous Drugs December 17,
Regulation of a License to Acquire, Board 2019
No. 8, S. Possess, and Use Unregistered
2019 Drug Products Containing
Dangerous Drugs for Personal
Use
DDB Immediate Adoption of Dangerous Drugs June 18, 2020
Regulation Changes in the Scope of Board
No. 1, S. Control of Substances
2020 Pursuant to the Three (3)
United Nations International
Drug Conventions

7
NATIONAL SERVICE TRAINING PROGRAM 1
6
 Module II: Drug Education

Topic 2
Role of the Youth on Drug Detection and Prevention

The role of the youth in the nation building is crucial. They are problem solvers, have a positive
influence in other young people and the nation, and are extremely ambitious. They have the ability to
create an identity for themselves and move the nation forward.

As drug abuse and addiction is prevalent in the younger generation. It is imperative that the youth
take part in its prevention and rehabilitation efforts. Youth groups or organizations can be a vehicle in
which their community can help alleviate or eradicate the possibility of drug abuse. Whether
individually or as a group, the youth is a good driving force that could shape the drug abuse
prevention initiative of the country.

Here are some ways the youth can step up in this endeavour:

1. Understand. Know the concept of reality of drug abuse. Having a grasp of the addiction
can help in avoiding it and watching out for others.
2. Listen. Open yourself in the knowledge of the experts and experiences of others that have
undergone the abuse. Hear the stories and lessons to the heart.
3. Share. Share your knowledge and network in aiding others towards being informed and
recognizing their role in drug prevention.
4. Encourage. Give your peers and family members a good push in the right direction,
whether its prevention or rehabilitation.
5. Support. Take part in activities beneficial in the drug abuse prevention initiative. Add
your presence in the growing force tackling this issues.
6. Organize. Great minds think alike. Having a mutual goal, it is more purposeful to
combine efforts and sources to create a bigger impact about the concern.
7. Inform. Approached appropriate government agencies regarding incidents and cases of
drug abuse.

As a responsible youth of today, be strong and always remember:

S – teadfats personality

T – rustworthy in words and deeds

R – espectable in relating with others

N – oble character

G – ustly actions and ideals

7
NATIONAL SERVICE TRAINING PROGRAM 1
7
 Module II: Drug Education

10 Ways to Say NO to Drugs

1. Be vocal, just say “NO” to drugs and mean it.
2. Project an image of a clean living for yourself.
3. Get into sports.
4. Choose your friends and influence them properly.
5. Get involved into community-based projects
6. Join organizations (church, school, community, or
social) or youth clubs or form your drama group.
7. Learn how to manage stress.
8. Join seminars on anti-drug abuse prevention.
9. Talk to your family, listen to the problems of your sisters and brothers.
10. Enhance your talent and skills by taking part on workshops, trainings, or seminars.

Government’s Response to the Problem

1. Preventive education programs
2. Treatment and rehabilitation programs
3. Intensifies campaigns against illegal drugs and trafficking
4. Judicial and legislative measures
5. National, regional and international cooperation to fight illegal trafficking and abuse of
dangerous drugs
6. Drug testing
7. Drug Information and Action Line

PDEA LEADS UNIFORM ANTI-DRUG PREVENTIVE

EDUCATION PROGRAM FOR SANGGUNIANG KABATAAN,
YOUTH
PRESS RELEASE: #049/20
DATE: February 17, 2020
The Philippine Drug Enforcement Agency (PDEA) is leading the newly institutionalized uniform
preventive education program intended for Sangguniang Kabataan (SK) and their youth constituents.
Known as “Sangguniang Kabataan Standard Training in Extensive Anti-Drug Preventive
Education – A Uniform Program for Youth Leaders (SK-STEP-UP), the program was approved and
adopted on June 27, 2019, under Dangerous Drugs Board (DDB) Board Regulation No. 5 Series of
2019.

7
NATIONAL SERVICE TRAINING PROGRAM 1
8
 Module II: Drug Education

“This paved the way to the guidelines institutionalizing a uniform preventive education program
in anti-drug advocacy complementing the demand reduction campaign for the youth leaders in the
community,” said PDEA Director General Aaron N. Aquino.
Speaking before 8,000 youth leaders during the SK Summit in Bren Guiao Convention Center in
the City of San Fernando, Pampanga on August 2, 2018, Aquino pushed for the creation of a uniform
anti-drug advocacy program for SK nationwide.
What is SK STEP-UP?
The SK STEP-UP is designed as a supervisory level preventive education training program aimed
at empowering the SK and barangay youth leaders to be Certified Anti-Drug Advocates cascading and
harmonizing the government’s drug demand reduction strategy down to the grassroots level.
The youth leaders of the community, specifically SK Chairpersons, its Councilors, selected Local
Youth Development Council members, and other equally qualified youth leaders who are at least 18
years old, but not more than 24 years of age, shall be responsible in the regular conduct of prevention
activities and organizing anti-drug events in their barangays, lead by example, and empower and
inspire their age groups to stay away from illegal drugs.
The SK STEP-UP has three phases namely: Youth Camp; Trainer’s Training for the Youth
Leaders; and Ground Implementation, Monitoring, and Evaluation.
Youth Camp
The Local Government Units (LGUs), through their Anti-Drug Abuse Councils (ADACs) shall
hold 2 to 3-day youth camp with local SK Federation Chairmen, Councilors, or selected youth leaders
as participants. Besides supervising the youth camp, PDEA shall provide the subject matter experts
(SMEs), camp program and mechanics. The LGU will be responsible for the logistical requirements
for the event.
During the camp, participants are expected to exchange ideas, cultural experiences, best practices,
talents, and related skills. They will be assessed by the program officials and coordinators based on
their competencies and leadership potential for them to be considered in the next phase.
Trainer’s Training for the Youth Leaders
In this phase, the LGUs, through their ADACs, are required to organize 3 to 5-day Trainer’s
Training of Youth Leaders for those participants who passed the competency requirement of Phase I.
The training modules include the SK STEP-UP Program’s Administration; Comprehensive Drug
Abuse Prevention Education (DAPE); Communication and Life Skills Development; Practical
Community Immersion; Basic Research and Development; and Formulation of Action Plans and
Implementation.
“Upon successful completion of the trainer’s training program, graduating participants will be
conferred the distinction as SK STEP-UP Certified Anti-Drug Advocates,” said Aquino.
Ground Implementation, Monitoring, and Evaluation
The new anti-drug advocates are expected to conduct the ground implementation of his/her action
plans for their respective barangays. They need to submit quarterly reports of barangay advocacies to
their ADACs, to monitor the functionality and operationalization of the program.
SK STEP-UP’s Concept of Implementation

7
NATIONAL SERVICE TRAINING PROGRAM 1
9
 Module II: Drug Education

PDEA, as the Chairman for the National Secretariat for the SK STEP-UP Program, shall
orchestrate, coordinate and oversee the successful implementation of the program, in collaboration
with the DDB, Department of the Interior and Local Government (DILG), National Youth
Commission (NYC), as members of the National Secretariat.
The program also requires participation from the Philippine National Police (PNP), Department of
Education (DepED), Department of Health (DOH), Commission on Higher Education (CHED),
Technical Education and Skills Development Authority (TESDA), Department of Social Welfare and
Development (DSWD), and Juvenile Justice and Welfare Council (JJWC), for technical, logistical,
security, intelligence, and other related assistance and support.
Funding
The primary source of funds shall be borne by the LGUs, in accordance with Section 51 of
Republic Act 9165, or “The Comprehensive Dangerous Drugs Act of 2002”, Section 16 of RA 7160,
or The Local Government Code, and DILG Joint Memorandum Circular No. 1 series of 2019. Private
corporations may also provide funding as part of their Corporate Social Responsibility (CSR).
Penalties
Failure on the part of concerned local executives and officials to perform their functions following
the provisions of Board Regulation No. 5, shall be ground for the filing of appropriate charges.
Likewise, the failure of the LGUs to appropriate a substantial portion of their Annual Budgets to
assist in the implementation of anti-drug advocacy programs in their communities shall be ground for
disapproval of their yearly budget.
“The youth is the voice of this nation. They have the energy and passion to help the government
solidify the future of our next generation. Let us give our young people the chance for their voices to
be heard,” the PDEA chief said.

8
NATIONAL SERVICE TRAINING PROGRAM 1
0